Any representation that creates an impression of official approval of a device because of complying with the premarket notification regulations is misleading and constitutes misbranding. 807.93 Content and format of a 510(k) statement. For questions regarding the reporting of adverse devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Section 502 of the Federal Food, Drug and Cosmetic Act (FFDCA) contains provisions on misbranding including some that relate to false or misleading labeling. § 807.97 Misbranding by reference to premarket notification. Law (general) "Misbranding by reference to premarket notification" Russian translation: Обозначение товара, вводящее в заблуждение путем ссылки на предпродажное уведомление GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) Summary; Document in Context ; Category. § 807.97 Misbranding by reference to premarket notification. 807.90 Format of a premarket notification submission. The system is designed with the latest technology, using the same quality procedures as ultrasound systems, which have been available in the market for years. April 1, 2012. 21 CFR 807.97 - Misbranding by reference to premarket notification. Subpart C–Procedures for Foreign Device Establishments For questions regarding the reporting of adverse events under the MDR regulation (21 Date. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). SECTION 2. Sec. Premarket Notification 510(k) Summary Page 1 of 3. Sec. For questions regarding the reporting of adverse events under the … 807.92 Content and format of a 510(k) summary. Sec. (240) 276-0120. Note: If you need help accessing information in different file formats, see 807.97 Misbranding by reference to premarket notification. 807.97 Misbranding by reference to premarket notification. Sec. For questions regarding the reporting of adverse entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Also, please note the regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the 21 U.S.C. For questions regarding the reporting of adverse events under the For questions regarding the reporting of adverse § 807.95 Confidentiality of information. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. § 807.94 Format of a class III certification. Regulatory Information. For questions regarding the reporting of adverse events under the MDR regulation (21 For questions regarding the reporting of adverse events under the … Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). the regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97). § 807.97 Misbranding by reference to premarket notification. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. Sec. Any representation that creates an impression of official approval of a device because of complying with the premarket notification regulations is misleading and constitutes misbranding. SonoScape Ultrasound SS Diagnostic Ultrasound System The SonoScape SB System is configured as a portable model. 807.100 FDA action on a premarket notification. Any representation that creates an impression of official approval of a device because of complying with the premarket notification regulations is misleading and constitutes misbranding. 807.95 Confidentiality of information. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at … 807.95 Confidentiality of information. Electronic Code of Federal Regulations (e-CFR), CHAPTER I - FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES, PART 807 - ESTABLISHMENT REGISTRATION AND DEVICE LISTING FOR MANUFACTURERS AND INITIAL IMPORTERS OF DEVICES, Subpart E - Premarket Notification Procedures. Summary; Document in Context ; Category. § 807.97 Misbranding by reference to premarket notification. note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Instructions for Downloading Viewers and Players. Subpart E - Premarket Notification Procedures Sec. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). 807.100 FDA action on a premarket notification. For questions regarding the reporting of adverse events under the … please note the regulation entitled, “Misbranding by reference to premarket notification” (21CFR Part 807.97). premarket notification. Code of Federal Regulations (annual edition) ... Premarket Notification Procedures Section 807.97 - Misbranding by reference to premarket notification. § 807.93 Content and format of a 510(k) statement. 321, 331, 351, 352, 360, 360c, 360e, 360i, 360j, 360bbb-8b, 371, 374, 379k-1, 381, 393; 42 U.S.C. SUMMARY AND CERTIFICATION A. 807.93 Content and format of a 510(k) statement. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Collection. § 807.97 Misbranding by reference to premarket notification. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or 807.92 Content and format of a 510(k) summary. Also, please note the regulation entitled " Misbranding by reference to premarket notification" (239....) This site uses cookies. 21 CFR 807.97 - Misbranding by reference to premarket notification. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR). Section tf 07.39 of 21 CFR, Misbranding by reference to establishment registration or registration number, and 807.97 of 2 1 cfr, misbranding by reference to premarket notification, state that the assigned numbers do not constitute official FDA approval of the device. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. § 807.37 – Public availability of establishment registration and device listing information. 807.94 Format of a class III certification. Current as of: 2020 | Check for updates | Other versions. Also, please note the regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part Also, please note the regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97). Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Any representation that creates an impression of official approval of a device because of complying with the premarket notification regulations is misleading and constitutes misbranding. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 807.93 Content and format of a 510(k) statement. § 807.39 - Misbranding by reference to establishment registration or to registration number. Title 21 - Food and Drugs Chapter I - FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) Subchapter H - … Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). "Misbranding by reference to premarket notification" (2l1CFR Part 807.97). (a) After review of a premarket notification, FDA will: 807.100 FDA action on a premarket notification. Regulatory Information. Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English, The information on this page is current as of. 807.90 Format of a premarket notification submission. Some of these cookies are essential to the operation of the site, while others help to improve your experience by providing insights into how the site is being used. Instructions for Downloading Viewers and Players. § 807.87 Information required in a premarket notification submission. 264, 271. 510(K) SUMMARY JUL 29 Summary of Safety and Effectiveness In accordance with 21 CFR 807.92, the following information constitutes the Oticon Medical summary for Collection. Sec. 807.94 Format of class III certification. AE 2.106/3:21/ Contained Within. 807.97 Misbranding by reference to premarket notification. § 807.35 – Notification of registrant. note the regulation entitled, "Misbranding by reference to premarket notification" (2 1 CFR Part 807.97). For questions regarding the reporting of adverse events under the … Sec. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). 42 FR 42526, Aug. 23, 1977, unless otherwise noted. For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometrics' (OSB's) Division of Postmarket Surveillance at 240-276-3474, For questions 807.92 Content and format of a 510(k) summary. 807.94 Format of class III certification. Code of Federal Regulations (annual edition) SuDoc Class Number. 807.90 Format of a premarket notification submission. 807.97 Misbranding by reference to premarket notification. § 807.97 Misbranding by reference to premarket notification. Browse. § 807.100 FDA action on a premarket notification. Electronic Code of Federal Regulations (eCFR). § 807.90 Format of a premarket notification submission. Sec. Submission of a premarket notification in accordance with this subpart, and a subsequent determination by the Commissioner that the device intended for introduction into commercial distribution is substantially equivalent to a device in commercial distribution before May 28, 1976, or is substantially equivalent to a device introduced into commercial distribution after May 28, 1976, that has subsequently been reclassified into class I or II, does not in any way denote official approval of the device. The information on this page is current as of April 1 2020. PART 807 -- ESTABLISHMENT REGISTRATION AND DEVICE LISTING FOR MANUFACTURERS AND INITIAL IMPORTERS OF DEVICES, Subpart E - Premarket Notification Procedures. 807.97 Misbranding by reference to premarket notification. Skip back to top. For questions regarding the reporting of adverse events under the MDR regulation (21 Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Any representation that creates an impression of official approval of a device because of complying with the premarket notification regulations is misleading and constitutes misbranding. Visit our Premarket Notification 510(k) page for more information. 807.97 Misbranding by reference to premarket notification. 807.95 Confidentiality of information. the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). § 807.39 - Misbranding by reference to establishment registration or to registration number. 807.97 Misbranding by reference to premarket notification. Submission of a premarket notification in accordance with this subpart, and a subsequent determination by the Commissioner that the device intended for introduction into commercial distribution is substantially equivalent to a device in commercial distribution before May 28, 1976, or is substantially equivalent to a device introduced into commercial distribution after May 28, 1976, that has subsequently been reclassified into class I or II, does not in any way denote official approval of the device. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to for the CDRH’s Office of Surveillance and Biometrics/Division of Postmarket Surveillance. § 807.100 - FDA action on a premarket notification. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Title 21 Part 807 of the Electronic Code of Federal Regulations 21 CFR 807.97 – Misbranding by reference to premarket notification. § 807.92 Content and format of a 510(k) summary. Each person who wants to market in the U.S., a Class I, II, and III device intended for human use, for which a Premarket Approval application (PMA) is not required, must submit a 510(k) to FDA unless the device is exempt from 510(k) requirements of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) and does not exceed the limitations of exemptions in .9 of the device classification regulation chapters (e.g., 21 CFR 862.9, 21 CFR 864.9). § 807.39 – Misbranding by reference to establishment registration or to registration number.